A Real Burn: Sunscreen Labeling in the Face of FDA Inaction
Show simple item record
| dc.contributor.advisor |
Peter Hutt |
en_US |
| dc.contributor.author |
Boychenko, Lisa |
|
| dc.date.accessioned |
2012-07-06T22:22:59Z |
|
| dc.date.issued |
2011 |
|
| dc.identifier.citation |
Lisa Boychenko, A Real Burn: Sunscreen Labeling in the Face of FDA Inaction (May 2011). |
en_US |
| dc.identifier.uri |
http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965639 |
|
| dc.description.abstract |
As rates of skin cancer continue to rise, sunscreen continues to be an essential tool in the fight against harmful UV radiation emanating from the sun. Sunscreen labeling greatly impacts the public’s perception of the risks of sun exposure, the protection obtained from a particular product, and the proper use of sunscreen. Thus, FDA regulation of sunscreen to prevent misleading labeling is an important aspect of public health. FDA began the rulemaking process for sunscreen products in 1978, but has yet to issue a final monograph that would legally bind sunscreen manufacturers. This prolonged rulemaking has resulted in many conclusions and proposed rules that would regulate sunscreen labels in order to encourage proper understanding of sun exposure danger and proper use of sunscreen products. However, since the regulations are not binding, manufacturers need not comply with FDA’s rules. Thus, the public has not benefited from FDA’s thorough analyses and proposed solutions to labeling, but instead has suffered and continues to suffer from FDA inaction. |
en_US |
| dash.license |
LAA |
|
| dc.subject.other |
Food and Drug Law |
en_US |
| dc.title |
A Real Burn: Sunscreen Labeling in the Face of FDA Inaction |
en_US |
| dc.type |
Paper (for course/seminar/workshop) |
en_US |
| dc.date.available |
2012-07-06T22:22:59Z |
|
Files in this item
This item appears in the following Collection(s)
Show simple item record
Contact administrator regarding this item (to report mistakes or request changes)
